{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T17:43:45Z","timestamp":1793727825730,"version":"4.6.1"},"reference-count":178,"publisher":"Springer Science and Business Media LLC","issue":"23","license":[{"start":{"date-parts":[[2021,10,27]],"date-time":"2021-10-27T00:00:00Z","timestamp":1635292800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,10,27]],"date-time":"2021-10-27T00:00:00Z","timestamp":1635292800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100000987","name":"melbourne research, university of melbourne","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000987","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell. Mol. Life Sci."],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1007\/s00018-021-03986-5","type":"journal-article","created":{"date-parts":[[2021,10,27]],"date-time":"2021-10-27T12:03:01Z","timestamp":1635336181000},"page":"7397-7426","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":84,"title":["Genomics of Alzheimer\u2019s disease implicates the innate and adaptive immune systems"],"prefix":"10.1007","volume":"78","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5784-3717","authenticated-orcid":false,"given":"Yihan","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon M.","family":"Laws","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luke A.","family":"Miles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James S.","family":"Wiley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin L.","family":"Masters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben J.","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,10,27]]},"reference":[{"issue":"10284","key":"3986_CR1","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1016\/s0140-6736(20)32205-4","volume":"397","author":"P Scheltens","year":"2021","unstructured":"Scheltens P, De Strooper B, Kivipelto M, Holstege H, Ch\u00e9telat G, Teunissen CE et al (2021) Alzheimer\u2019s disease. Lancet 397(10284):1577\u20131590. https:\/\/doi.org\/10.1016\/s0140-6736(20)32205-4","journal-title":"Lancet"},{"issue":"6","key":"3986_CR2","doi-asserted-by":"publisher","first-page":"595","DOI":"10.15252\/emmm.201606210","volume":"8","author":"DJ Selkoe","year":"2016","unstructured":"Selkoe DJ, Hardy J (2016) The amyloid hypothesis of Alzheimer\u2019s disease at 25 years. EMBO Mol Med 8(6):595\u2013608. https:\/\/doi.org\/10.15252\/emmm.201606210","journal-title":"EMBO Mol Med"},{"key":"3986_CR3","doi-asserted-by":"publisher","DOI":"10.1126\/science.abb8255","author":"CW Chang","year":"2021","unstructured":"Chang CW, Shao E, Mucke L (2021) Tau: enabler of diverse brain disorders and target of rapidly evolving therapeutic strategies. Science. https:\/\/doi.org\/10.1126\/science.abb8255","journal-title":"Science"},{"issue":"9","key":"3986_CR4","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1016\/j.jmb.2019.01.045","volume":"431","author":"A McQuade","year":"2019","unstructured":"McQuade A, Blurton-Jones M (2019) Microglia in Alzheimer\u2019s disease: exploring how genetics and phenotype influence risk. J Mol Biol 431(9):1805\u20131817. https:\/\/doi.org\/10.1016\/j.jmb.2019.01.045","journal-title":"J Mol Biol"},{"issue":"6","key":"3986_CR5","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/j.jalz.2016.02.010","volume":"12","author":"V Calsolaro","year":"2016","unstructured":"Calsolaro V, Edison P (2016) Neuroinflammation in Alzheimer\u2019s disease: current evidence and future directions. Alzheimers Dement 12(6):719\u2013732. https:\/\/doi.org\/10.1016\/j.jalz.2016.02.010","journal-title":"Alzheimers Dement"},{"issue":"2","key":"3986_CR6","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1083\/jcb.201709069","volume":"217","author":"DV Hansen","year":"2018","unstructured":"Hansen DV, Hanson JE, Sheng M (2018) Microglia in Alzheimer\u2019s disease. J Cell Biol 217(2):459\u2013472. https:\/\/doi.org\/10.1083\/jcb.201709069","journal-title":"J Cell Biol"},{"issue":"2\u20133","key":"3986_CR7","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.ijdevneu.2005.11.014","volume":"24","author":"M Sastre","year":"2006","unstructured":"Sastre M, Klockgether T, Heneka MT (2006) Contribution of inflammatory processes to Alzheimer\u2019s disease: molecular mechanisms. Int J Dev Neurosci 24(2\u20133):167\u2013176. https:\/\/doi.org\/10.1016\/j.ijdevneu.2005.11.014","journal-title":"Int J Dev Neurosci"},{"issue":"5","key":"3986_CR8","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1042\/BST20140155","volume":"42","author":"EC Phillips","year":"2014","unstructured":"Phillips EC, Croft CL, Kurbatskaya K, O\u2019Neill MJ, Hutton ML, Hanger DP et al (2014) Astrocytes and neuroinflammation in Alzheimer\u2019s disease. Biochem Soc Trans 42(5):1321\u20131325. https:\/\/doi.org\/10.1042\/BST20140155","journal-title":"Biochem Soc Trans"},{"issue":"3","key":"3986_CR9","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","volume":"7","author":"GM McKhann","year":"2011","unstructured":"McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR Jr, Kawas CH et al (2011) The diagnosis of dementia due to Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimers Dement 7(3):263\u2013269. https:\/\/doi.org\/10.1016\/j.jalz.2011.03.005","journal-title":"Alzheimers Dement"},{"issue":"4","key":"3986_CR10","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/j.cell.2015.12.056","volume":"164","author":"B De Strooper","year":"2016","unstructured":"De Strooper B, Karran E (2016) The cellular phase of Alzheimer\u2019s disease. Cell 164(4):603\u2013615. https:\/\/doi.org\/10.1016\/j.cell.2015.12.056","journal-title":"Cell"},{"issue":"3","key":"3986_CR11","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.jalz.2011.03.003","volume":"7","author":"RA Sperling","year":"2011","unstructured":"Sperling RA, Aisen PS, Beckett LA, Bennett DA, Craft S, Fagan AM et al (2011) Toward defining the preclinical stages of Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimers Dement 7(3):280\u2013292. https:\/\/doi.org\/10.1016\/j.jalz.2011.03.003","journal-title":"Alzheimers Dement"},{"key":"3986_CR12","doi-asserted-by":"publisher","first-page":"104976","DOI":"10.1016\/j.nbd.2020.104976","volume":"143","author":"SM Neuner","year":"2020","unstructured":"Neuner SM, Tcw J, Goate AM (2020) Genetic architecture of Alzheimer\u2019s disease. Neurobiol Dis 143:104976. https:\/\/doi.org\/10.1016\/j.nbd.2020.104976","journal-title":"Neurobiol Dis"},{"issue":"3","key":"3986_CR13","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/s41593-020-0599-5","volume":"23","author":"R Sims","year":"2020","unstructured":"Sims R, Hill M, Williams J (2020) The multiplex model of the genetics of Alzheimer\u2019s disease. Nat Neurosci 23(3):311\u2013322. https:\/\/doi.org\/10.1038\/s41593-020-0599-5","journal-title":"Nat Neurosci"},{"issue":"6","key":"3986_CR14","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/j.jalz.2016.01.012","volume":"12","author":"R Cacace","year":"2016","unstructured":"Cacace R, Sleegers K, Van Broeckhoven C (2016) Molecular genetics of early-onset Alzheimer\u2019s disease revisited. Alzheimers Dement 12(6):733\u2013748. https:\/\/doi.org\/10.1016\/j.jalz.2016.01.012","journal-title":"Alzheimers Dement"},{"issue":"44","key":"3986_CR15","doi-asserted-by":"publisher","first-page":"29615","DOI":"10.1074\/jbc.R800019200","volume":"283","author":"G Thinakaran","year":"2008","unstructured":"Thinakaran G, Koo EH (2008) Amyloid precursor protein trafficking, processing, and function. J Biol Chem 283(44):29615\u201329619. https:\/\/doi.org\/10.1074\/jbc.R800019200","journal-title":"J Biol Chem"},{"issue":"8873","key":"3986_CR16","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/0140-6736(93)91705-q","volume":"342","author":"J Poirier","year":"1993","unstructured":"Poirier J, Davignon J, Bouthillier D, Kogan S, Bertrand P, Gauthier S (1993) Apolipoprotein E polymorphism and Alzheimer\u2019s disease. Lancet 342(8873):697\u2013699. https:\/\/doi.org\/10.1016\/0140-6736(93)91705-q","journal-title":"Lancet"},{"issue":"8","key":"3986_CR17","doi-asserted-by":"publisher","first-page":"e1003289","DOI":"10.1371\/journal.pmed.1003289","volume":"17","author":"H Saddiki","year":"2020","unstructured":"Saddiki H, Fayosse A, Cognat E, Sabia S, Engelborghs S, Wallon D et al (2020) Age and the association between apolipoprotein E genotype and Alzheimer disease: a cerebrospinal fluid biomarker-based case-control study. PLoS Med 17(8):e1003289. https:\/\/doi.org\/10.1371\/journal.pmed.1003289","journal-title":"PLoS Med"},{"issue":"4","key":"3986_CR18","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/S1474-4422(19)30435-1","volume":"19","author":"SJ Andrews","year":"2020","unstructured":"Andrews SJ, Fulton-Howard B, Goate A (2020) Interpretation of risk loci from genome-wide association studies of Alzheimer\u2019s disease. Lancet Neurol 19(4):326\u2013335. https:\/\/doi.org\/10.1016\/S1474-4422(19)30435-1","journal-title":"Lancet Neurol"},{"issue":"2","key":"3986_CR19","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s12264-016-0011-3","volume":"32","author":"L Shen","year":"2016","unstructured":"Shen L, Jia J (2016) An overview of genome-wide association studies in Alzheimer\u2019s disease. Neurosci Bull 32(2):183\u2013190. https:\/\/doi.org\/10.1007\/s12264-016-0011-3","journal-title":"Neurosci Bull"},{"issue":"10","key":"3986_CR20","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1038\/ng.440","volume":"41","author":"D Harold","year":"2009","unstructured":"Harold D, Abraham R, Hollingworth P, Sims R, Gerrish A, Hamshere ML et al (2009) Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer\u2019s disease. Nat Genet 41(10):1088\u20131093. https:\/\/doi.org\/10.1038\/ng.440","journal-title":"Nat Genet"},{"issue":"10","key":"3986_CR21","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1038\/ng.439","volume":"41","author":"JC Lambert","year":"2009","unstructured":"Lambert JC, Heath S, Even G, Campion D, Sleegers K, Hiltunen M et al (2009) Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer\u2019s disease. Nat Genet 41(10):1094\u20131099. https:\/\/doi.org\/10.1038\/ng.439","journal-title":"Nat Genet"},{"issue":"12","key":"3986_CR22","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1001\/archneurol.2010.201","volume":"67","author":"G Jun","year":"2010","unstructured":"Jun G, Naj AC, Beecham GW, Wang LS, Buros J, Gallins PJ et al (2010) Meta-analysis confirms CR1, CLU, and PICALM as alzheimer disease risk loci and reveals interactions with APOE genotypes. Arch Neurol 67(12):1473\u20131484. https:\/\/doi.org\/10.1001\/archneurol.2010.201","journal-title":"Arch Neurol"},{"issue":"18","key":"3986_CR23","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.1001\/jama.2010.574","volume":"303","author":"S Seshadri","year":"2010","unstructured":"Seshadri S, Fitzpatrick AL, Ikram MA, DeStefano AL, Gudnason V, Boada M et al (2010) Genome-wide analysis of genetic loci associated with Alzheimer disease. JAMA 303(18):1832\u20131840. https:\/\/doi.org\/10.1001\/jama.2010.574","journal-title":"JAMA"},{"issue":"5","key":"3986_CR24","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1038\/ng.801","volume":"43","author":"AC Naj","year":"2011","unstructured":"Naj AC, Jun G, Beecham GW, Wang LS, Vardarajan BN, Buros J et al (2011) Common variants at MS4A4\/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer\u2019s disease. Nat Genet 43(5):436\u2013441. https:\/\/doi.org\/10.1038\/ng.801","journal-title":"Nat Genet"},{"issue":"5","key":"3986_CR25","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/ng.803","volume":"43","author":"P Hollingworth","year":"2011","unstructured":"Hollingworth P, Harold D, Sims R, Gerrish A, Lambert JC, Carrasquillo MM et al (2011) Common variants at ABCA7, MS4A6A\/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer\u2019s disease. Nat Genet 43(5):429\u2013435. https:\/\/doi.org\/10.1038\/ng.803","journal-title":"Nat Genet"},{"issue":"12","key":"3986_CR26","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1038\/ng.2802","volume":"45","author":"JC Lambert","year":"2013","unstructured":"Lambert JC, Ibrahim-Verbaas CA, Harold D, Naj AC, Sims R, Bellenguez C et al (2013) Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer\u2019s disease. Nat Genet 45(12):1452\u20131458. https:\/\/doi.org\/10.1038\/ng.2802","journal-title":"Nat Genet"},{"key":"3986_CR27","doi-asserted-by":"publisher","unstructured":"Convergent genetic and expression data implicate immunity in Alzheimer's disease (2015). Alzheimers Dement 11(6):658\u2013671. https:\/\/doi.org\/10.1016\/j.jalz.2014.05.1757","DOI":"10.1016\/j.jalz.2014.05.1757"},{"issue":"6","key":"3986_CR28","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1038\/s41588-018-0129-5","volume":"50","author":"NG Skene","year":"2018","unstructured":"Skene NG, Bryois J, Bakken TE, Breen G, Crowley JJ, Gaspar HA et al (2018) Genetic identification of brain cell types underlying schizophrenia. Nat Genet 50(6):825\u2013833. https:\/\/doi.org\/10.1038\/s41588-018-0129-5","journal-title":"Nat Genet"},{"issue":"1","key":"3986_CR29","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/s41398-018-0150-6","volume":"8","author":"RE Marioni","year":"2018","unstructured":"Marioni RE, Harris SE, Zhang Q, McRae AF, Hagenaars SP, Hill WD et al (2018) GWAS on family history of Alzheimer\u2019s disease. Transl Psychiatry 8(1):99. https:\/\/doi.org\/10.1038\/s41398-018-0150-6","journal-title":"Transl Psychiatry"},{"issue":"3","key":"3986_CR30","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1038\/s41588-018-0311-9","volume":"51","author":"IE Jansen","year":"2019","unstructured":"Jansen IE, Savage JE, Watanabe K, Bryois J, Williams DM, Steinberg S et al (2019) Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer\u2019s disease risk. Nat Genet 51(3):404\u2013413. https:\/\/doi.org\/10.1038\/s41588-018-0311-9","journal-title":"Nat Genet"},{"issue":"3","key":"3986_CR31","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1038\/s41588-019-0358-2","volume":"51","author":"BW Kunkle","year":"2019","unstructured":"Kunkle BW, Grenier-Boley B, Sims R, Bis JC, Damotte V, Naj AC et al (2019) Genetic meta-analysis of diagnosed Alzheimer\u2019s disease identifies new risk loci and implicates Abeta, tau, immunity and lipid processing. Nat Genet 51(3):414\u2013430. https:\/\/doi.org\/10.1038\/s41588-019-0358-2","journal-title":"Nat Genet"},{"issue":"3","key":"3986_CR32","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1038\/s41588-020-00776-w","volume":"53","author":"J Schwartzentruber","year":"2021","unstructured":"Schwartzentruber J, Cooper S, Liu JZ, Barrio-Hernandez I, Bello E, Kumasaka N et al (2021) Genome-wide meta-analysis, fine-mapping and integrative prioritization implicate new Alzheimer\u2019s disease risk genes. Nat Genet 53(3):392\u2013402. https:\/\/doi.org\/10.1038\/s41588-020-00776-w","journal-title":"Nat Genet"},{"key":"3986_CR33","doi-asserted-by":"publisher","DOI":"10.1101\/2020.10.01.20200659","author":"C Bellenguez","year":"2020","unstructured":"Bellenguez C, K\u00fc\u00e7\u00fckali F, Jansen I, Andrade V, Moreno-Grau S, Amin N et al (2020) New insights on the genetic etiology of Alzheimer\u2019s and related dementia. medRxiv. https:\/\/doi.org\/10.1101\/2020.10.01.20200659","journal-title":"medRxiv"},{"key":"3986_CR34","doi-asserted-by":"publisher","DOI":"10.1101\/2020.11.20.20235275","author":"DP Wightman","year":"2020","unstructured":"Wightman DP, Jansen IE, Savage JE, Shadrin AA, Bahrami S, Rongve A et al (2020) Largest GWAS (N=1,126,563) of Alzheimer\u2019s disease implicates microglia and immune cells. medRxiv. https:\/\/doi.org\/10.1101\/2020.11.20.20235275","journal-title":"medRxiv"},{"issue":"1","key":"3986_CR35","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/mp.2015.23","volume":"21","author":"G Jun","year":"2016","unstructured":"Jun G, Ibrahim-Verbaas CA, Vronskaya M, Lambert JC, Chung J, Naj AC et al (2016) A novel Alzheimer disease locus located near the gene encoding tau protein. Mol Psychiatry 21(1):108\u2013117. https:\/\/doi.org\/10.1038\/mp.2015.23","journal-title":"Mol Psychiatry"},{"key":"3986_CR36","doi-asserted-by":"publisher","DOI":"10.1101\/2020.07.02.20145557","author":"S Kang","year":"2021","unstructured":"Kang S, Gim J, Gunasekaran TI, Choi KY, Lee JJ, Seo EH et al (2021) APOE-stratified genome-wide association study suggests potential novel genes for late-onset Alzheimer\u2019s disease in East-Asian descent. medRxiv. https:\/\/doi.org\/10.1101\/2020.07.02.20145557","journal-title":"medRxiv"},{"issue":"1","key":"3986_CR37","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1093\/nar\/29.1.308","volume":"29","author":"ST Sherry","year":"2001","unstructured":"Sherry ST, Ward MH, Kholodov M, Baker J, Phan L, Smigielski EM et al (2001) dbSNP: the NCBI database of genetic variation. Nucleic Acids Res 29(1):308\u2013311. https:\/\/doi.org\/10.1093\/nar\/29.1.308","journal-title":"Nucleic Acids Res"},{"issue":"6469","key":"3986_CR38","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1126\/science.aay0793","volume":"366","author":"A Nott","year":"2019","unstructured":"Nott A, Holtman IR, Coufal NG, Schlachetzki JCM, Yu M, Hu R et al (2019) Brain cell type-specific enhancer-promoter interactome maps and disease-risk association. Science 366(6469):1134\u20131139. https:\/\/doi.org\/10.1126\/science.aay0793","journal-title":"Science"},{"issue":"9","key":"3986_CR39","doi-asserted-by":"publisher","first-page":"2759","DOI":"10.1038\/s41596-020-0353-1","volume":"15","author":"SW Choi","year":"2020","unstructured":"Choi SW, Mak TS-H, O\u2019Reilly PF (2020) Tutorial: a guide to performing polygenic risk score analyses. Nat Protoc 15(9):2759\u20132772. https:\/\/doi.org\/10.1038\/s41596-020-0353-1","journal-title":"Nat Protoc"},{"key":"3986_CR40","doi-asserted-by":"publisher","first-page":"214.e217","DOI":"10.1016\/j.neurobiolaging.2016.07.018","volume":"49","author":"V Escott-Price","year":"2017","unstructured":"Escott-Price V, Shoai M, Pither R, Williams J, Hardy J (2017) Polygenic score prediction captures nearly all common genetic risk for Alzheimer\u2019s disease. Neurobiol Aging 49:214.e217-214.e211. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2016.07.018","journal-title":"Neurobiol Aging"},{"issue":"3","key":"3986_CR41","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1002\/acn3.716","volume":"6","author":"G Leonenko","year":"2019","unstructured":"Leonenko G, Sims R, Shoai M, Frizzati A, Boss\u00f9 P, Spalletta G et al (2019) Polygenic risk and hazard scores for Alzheimer\u2019s disease prediction. Ann Clin Transl Neurol 6(3):456\u2013465. https:\/\/doi.org\/10.1002\/acn3.716","journal-title":"Ann Clin Transl Neurol"},{"issue":"3","key":"3986_CR42","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/s41380-018-0030-8","volume":"24","author":"MW Logue","year":"2019","unstructured":"Logue MW, Panizzon MS, Elman JA, Gillespie NA, Hatton SN, Gustavson DE et al (2019) Use of an Alzheimer\u2019s disease polygenic risk score to identify mild cognitive impairment in adults in their 50s. Mol Psychiatry 24(3):421\u2013430. https:\/\/doi.org\/10.1038\/s41380-018-0030-8","journal-title":"Mol Psychiatry"},{"issue":"1","key":"3986_CR43","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s13195-020-00754-8","volume":"13","author":"A Zettergren","year":"2021","unstructured":"Zettergren A, Lord J, Ashton NJ, Benedet AL, Karikari TK, Lantero Rodriguez J et al (2021) Association between polygenic risk score of Alzheimer\u2019s disease and plasma phosphorylated tau in individuals from the Alzheimer\u2019s Disease Neuroimaging Initiative. Alzheimer\u2019s Res Therapy 13(1):17. https:\/\/doi.org\/10.1186\/s13195-020-00754-8","journal-title":"Alzheimer's Res Therapy"},{"key":"3986_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-020-0764-y","author":"H Stocker","year":"2020","unstructured":"Stocker H, Perna L, Weigl K, M\u00f6llers T, Sch\u00f6ttker B, Thomsen H et al (2020) Prediction of clinical diagnosis of Alzheimer\u2019s disease, vascular, mixed, and all-cause dementia by a polygenic risk score and APOE status in a community-based cohort prospectively followed over 17 years. Mol Psychiatry. https:\/\/doi.org\/10.1038\/s41380-020-0764-y","journal-title":"Mol Psychiatry"},{"issue":"2","key":"3986_CR45","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.jalz.2017.08.013","volume":"14","author":"C Cruchaga","year":"2018","unstructured":"Cruchaga C, Del-Aguila JL, Saef B, Black K, Fernandez MV, Budde J et al (2018) Polygenic risk score of sporadic late-onset Alzheimer\u2019s disease reveals a shared architecture with the familial and early-onset forms. Alzheimers Dement 14(2):205\u2013214. https:\/\/doi.org\/10.1016\/j.jalz.2017.08.013","journal-title":"Alzheimers Dement"},{"issue":"1","key":"3986_CR46","doi-asserted-by":"publisher","first-page":"e12074","DOI":"10.1002\/dad2.12074","volume":"12","author":"X Zhou","year":"2020","unstructured":"Zhou X, Chen Y, Ip FCF, Lai NCH, Li YYT, Jiang Y et al (2020) Genetic and polygenic risk score analysis for Alzheimer\u2019s disease in the Chinese population. Alzheimer\u2019s Dement 12(1):e12074\u2013e12074. https:\/\/doi.org\/10.1002\/dad2.12074","journal-title":"Alzheimer's Dement"},{"issue":"2","key":"3986_CR47","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1056\/NEJMoa1211103","volume":"368","author":"T Jonsson","year":"2013","unstructured":"Jonsson T, Stefansson H, Steinberg S, Jonsdottir I, Jonsson PV, Snaedal J et al (2013) Variant of TREM2 associated with the risk of Alzheimer\u2019s disease. N Engl J Med 368(2):107\u2013116. https:\/\/doi.org\/10.1056\/NEJMoa1211103","journal-title":"N Engl J Med"},{"issue":"2","key":"3986_CR48","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1056\/NEJMoa1211851","volume":"368","author":"R Guerreiro","year":"2013","unstructured":"Guerreiro R, Wojtas A, Bras J, Carrasquillo M, Rogaeva E, Majounie E et al (2013) TREM2 variants in Alzheimer\u2019s disease. N Engl J Med 368(2):117\u2013127. https:\/\/doi.org\/10.1056\/NEJMoa1211851","journal-title":"N Engl J Med"},{"issue":"8","key":"3986_CR49","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/S1474-4422(18)30232-1","volume":"17","author":"S Carmona","year":"2018","unstructured":"Carmona S, Zahs K, Wu E, Dakin K, Bras J, Guerreiro R (2018) The role of TREM2 in Alzheimer\u2019s disease and other neurodegenerative disorders. Lancet Neurol 17(8):721\u2013730. https:\/\/doi.org\/10.1016\/S1474-4422(18)30232-1","journal-title":"Lancet Neurol"},{"issue":"21","key":"3986_CR50","doi-asserted-by":"publisher","first-page":"5838","DOI":"10.1093\/hmg\/ddu277","volume":"23","author":"SC Jin","year":"2014","unstructured":"Jin SC, Benitez BA, Karch CM, Cooper B, Skorupa T, Carrell D et al (2014) Coding variants in TREM2 increase risk for Alzheimer\u2019s disease. Hum Mol Genet 23(21):5838\u20135846. https:\/\/doi.org\/10.1093\/hmg\/ddu277","journal-title":"Hum Mol Genet"},{"issue":"9","key":"3986_CR51","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1038\/ng.3916","volume":"49","author":"R Sims","year":"2017","unstructured":"Sims R, van der Lee SJ, Naj AC, Bellenguez C, Badarinarayan N, Jakobsdottir J et al (2017) Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer\u2019s disease. Nat Genet 49(9):1373\u20131384. https:\/\/doi.org\/10.1038\/ng.3916","journal-title":"Nat Genet"},{"issue":"1","key":"3986_CR52","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s40478-016-0367-7","volume":"4","author":"DW Sirkis","year":"2016","unstructured":"Sirkis DW, Bonham LW, Aparicio RE, Geier EG, Ramos EM, Wang Q et al (2016) Rare TREM2 variants associated with Alzheimer\u2019s disease display reduced cell surface expression. Acta Neuropathol Commun 4(1):98. https:\/\/doi.org\/10.1186\/s40478-016-0367-7","journal-title":"Acta Neuropathol Commun"},{"key":"3986_CR53","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s13024-015-0016-9","volume":"10","author":"SC Jin","year":"2015","unstructured":"Jin SC, Carrasquillo MM, Benitez BA, Skorupa T, Carrell D, Patel D et al (2015) TREM2 is associated with increased risk for Alzheimer\u2019s disease in African Americans. Mol Neurodegener 10:19. https:\/\/doi.org\/10.1186\/s13024-015-0016-9","journal-title":"Mol Neurodegener"},{"issue":"10","key":"3986_CR54","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1002\/acn3.51197","volume":"7","author":"W Zhang","year":"2020","unstructured":"Zhang W, Jiao B, Xiao T, Liu X, Liao X, Xiao X et al (2020) Association of rare variants in neurodegenerative genes with familial Alzheimer\u2019s disease. Ann Clin Transl Neurol 7(10):1985\u20131995. https:\/\/doi.org\/10.1002\/acn3.51197","journal-title":"Ann Clin Transl Neurol"},{"issue":"2","key":"3986_CR55","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/ng1943","volume":"39","author":"E Rogaeva","year":"2007","unstructured":"Rogaeva E, Meng Y, Lee JH, Gu Y, Kawarai T, Zou F et al (2007) The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease. Nat Genet 39(2):168\u2013177. https:\/\/doi.org\/10.1038\/ng1943","journal-title":"Nat Genet"},{"issue":"2","key":"3986_CR56","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s00401-019-01991-4","volume":"138","author":"D Campion","year":"2019","unstructured":"Campion D, Charbonnier C, Nicolas G (2019) SORL1 genetic variants and Alzheimer disease risk: a literature review and meta-analysis of sequencing data. Acta Neuropathol 138(2):173\u2013186. https:\/\/doi.org\/10.1007\/s00401-019-01991-4","journal-title":"Acta Neuropathol"},{"issue":"2","key":"3986_CR57","doi-asserted-by":"publisher","first-page":"463","DOI":"10.3233\/JAD-170639","volume":"61","author":"CD Pereira","year":"2018","unstructured":"Pereira CD, Martins F, Wiltfang J, da Cruz ESOAB, Rebelo S (2018) ABC transporters are key players in Alzheimer\u2019s disease. J Alzheimers Dis 61(2):463\u2013485. https:\/\/doi.org\/10.3233\/JAD-170639","journal-title":"J Alzheimers Dis"},{"key":"3986_CR58","doi-asserted-by":"publisher","first-page":"235 e231","DOI":"10.1016\/j.neurobiolaging.2016.04.004","volume":"46","author":"C Sassi","year":"2016","unstructured":"Sassi C, Nalls MA, Ridge PG, Gibbs JR, Ding J, Lupton MK et al (2016) ABCA7 p. G215S as potential protective factor for Alzheimer\u2019s disease. Neurobiol Aging 46:235 e231-239. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2016.04.004","journal-title":"Neurobiol Aging"},{"issue":"5","key":"3986_CR59","doi-asserted-by":"publisher","first-page":"e194","DOI":"10.1212\/NXG.0000000000000194","volume":"3","author":"GW Beecham","year":"2017","unstructured":"Beecham GW, Bis JC, Martin ER, Choi SH, DeStefano AL, van Duijn CM et al (2017) The Alzheimer\u2019s Disease Sequencing Project: study design and sample selection. Neurology Genetics 3(5):e194. https:\/\/doi.org\/10.1212\/NXG.0000000000000194","journal-title":"Neurology Genetics"},{"issue":"7","key":"3986_CR60","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1002\/acn3.582","volume":"5","author":"NS Raghavan","year":"2018","unstructured":"Raghavan NS, Brickman AM, Andrews H, Manly JJ, Schupf N, Lantigua R et al (2018) Whole-exome sequencing in 20,197 persons for rare variants in Alzheimer\u2019s disease. Ann Clin Transl Neurol 5(7):832\u2013842. https:\/\/doi.org\/10.1002\/acn3.582","journal-title":"Ann Clin Transl Neurol"},{"issue":"8","key":"3986_CR61","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1038\/s41380-018-0112-7","volume":"25","author":"JC Bis","year":"2020","unstructured":"Bis JC, Jian X, Kunkle BW, Chen Y, Hamilton-Nelson KL, Bush WS et al (2020) Whole exome sequencing study identifies novel rare and common Alzheimer\u2019s-associated variants involved in immune response and transcriptional regulation. Mol Psychiatry 25(8):1859\u20131875. https:\/\/doi.org\/10.1038\/s41380-018-0112-7","journal-title":"Mol Psychiatry"},{"issue":"4","key":"3986_CR62","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.3233\/JAD-200037","volume":"76","author":"KH Fan","year":"2020","unstructured":"Fan KH, Feingold E, Rosenthal SL, Demirci FY, Ganguli M, Lopez OL et al (2020) Whole-exome sequencing analysis of Alzheimer\u2019s disease in non-APOE*4 carriers. J Alzheimers Dis 76(4):1553\u20131565. https:\/\/doi.org\/10.3233\/JAD-200037","journal-title":"J Alzheimers Dis"},{"issue":"3","key":"3986_CR63","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1111\/ahg.12375","volume":"84","author":"D Curtis","year":"2020","unstructured":"Curtis D, Bakaya K, Sharma L, Bandyopadhyay S (2020) Weighted burden analysis of exome-sequenced late-onset Alzheimer\u2019s cases and controls provides further evidence for a role for PSEN1 and suggests involvement of the PI3K\/Akt\/GSK-3beta and WNT signalling pathways. Ann Hum Genet 84(3):291\u2013302. https:\/\/doi.org\/10.1111\/ahg.12375","journal-title":"Ann Hum Genet"},{"issue":"S2","key":"3986_CR64","doi-asserted-by":"publisher","first-page":"e041592","DOI":"10.1002\/alz.041592","volume":"16","author":"H Holstege","year":"2020","unstructured":"Holstege H, Hulsman M, Charbonnier C, Grenier-Boley B, Quenez O, Ahmad S et al (2020) Exome sequencing identifies three novel AD-associated genes. Alzheimers Dement 16(S2):e041592. https:\/\/doi.org\/10.1002\/alz.041592","journal-title":"Alzheimers Dement"},{"issue":"6","key":"3986_CR65","doi-asserted-by":"publisher","first-page":"e286","DOI":"10.1212\/NXG.0000000000000286","volume":"4","author":"GW Beecham","year":"2018","unstructured":"Beecham GW, Vardarajan B, Blue E, Bush W, Jaworski J, Barral S et al (2018) Rare genetic variation implicated in non-Hispanic white families with Alzheimer disease. Neurol Genet 4(6):e286. https:\/\/doi.org\/10.1212\/NXG.0000000000000286","journal-title":"Neurol Genet"},{"issue":"4","key":"3986_CR66","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1002\/acn3.537","volume":"5","author":"BN Vardarajan","year":"2018","unstructured":"Vardarajan BN, Barral S, Jaworski J, Beecham GW, Blue E, Tosto G et al (2018) Whole genome sequencing of Caribbean Hispanic families with late-onset Alzheimer\u2019s disease. Ann Clin Transl Neurol 5(4):406\u2013417. https:\/\/doi.org\/10.1002\/acn3.537","journal-title":"Ann Clin Transl Neurol"},{"key":"3986_CR67","doi-asserted-by":"publisher","DOI":"10.1002\/alz.12319","author":"D Prokopenko","year":"2021","unstructured":"Prokopenko D, Morgan SL, Mullin K, Hofmann O, Chapman B, Kirchner R et al (2021) Whole-genome sequencing reveals new Alzheimer\u2019s disease-associated rare variants in loci related to synaptic function and neuronal development. Alzheimers Dement. https:\/\/doi.org\/10.1002\/alz.12319","journal-title":"Alzheimers Dement"},{"issue":"3","key":"3986_CR68","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1111\/nan.12465","volume":"44","author":"M Leija-Salazar","year":"2018","unstructured":"Leija-Salazar M, Piette C, Proukakis C (2018) Review: somatic mutations in neurodegeneration. Neuropathol Appl Neurobiol 44(3):267\u2013285. https:\/\/doi.org\/10.1111\/nan.12465","journal-title":"Neuropathol Appl Neurobiol"},{"key":"3986_CR69","doi-asserted-by":"publisher","first-page":"105021","DOI":"10.1016\/j.nbd.2020.105021","volume":"144","author":"C Proukakis","year":"2020","unstructured":"Proukakis C (2020) Somatic mutations in neurodegeneration: an update. Neurobiol Dis 144:105021. https:\/\/doi.org\/10.1016\/j.nbd.2020.105021","journal-title":"Neurobiol Dis"},{"issue":"5","key":"3986_CR70","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/nrg3424","volume":"14","author":"LG Biesecker","year":"2013","unstructured":"Biesecker LG, Spinner NB (2013) A genomic view of mosaicism and human disease. Nat Rev Genet 14(5):307\u2013320. https:\/\/doi.org\/10.1038\/nrg3424","journal-title":"Nat Rev Genet"},{"key":"3986_CR71","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a025130","author":"S Maynard","year":"2015","unstructured":"Maynard S, Fang EF, Scheibye-Knudsen M, Croteau DL, Bohr VA (2015) DNA damage, DNA repair, aging, and neurodegeneration. Cold Spring Harb Perspect Med. https:\/\/doi.org\/10.1101\/cshperspect.a025130","journal-title":"Cold Spring Harb Perspect Med"},{"key":"3986_CR72","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21051666","author":"X Lin","year":"2020","unstructured":"Lin X, Kapoor A, Gu Y, Chow MJ, Peng J, Zhao K et al (2020) Contributions of DNA damage to Alzheimer\u2019s disease. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms21051666","journal-title":"Int J Mol Sci"},{"key":"3986_CR73","doi-asserted-by":"publisher","DOI":"10.1126\/science.aal1641","author":"MJ McConnell","year":"2017","unstructured":"McConnell MJ, Moran JV, Abyzov A, Akbarian S, Bae T, Cortes-Ciriano I et al (2017) Intersection of diverse neuronal genomes and neuropsychiatric disease: the brain somatic mosaicism network. Science. https:\/\/doi.org\/10.1126\/science.aal1641","journal-title":"Science"},{"issue":"6256","key":"3986_CR74","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1126\/science.aab1785","volume":"350","author":"MA Lodato","year":"2015","unstructured":"Lodato MA, Woodworth MB, Lee S, Evrony GD, Mehta BK, Karger A et al (2015) Somatic mutation in single human neurons tracks developmental and transcriptional history. Science 350(6256):94\u201398. https:\/\/doi.org\/10.1126\/science.aab1785","journal-title":"Science"},{"issue":"6375","key":"3986_CR75","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1126\/science.aao4426","volume":"359","author":"MA Lodato","year":"2018","unstructured":"Lodato MA, Rodin RE, Bohrson CL, Coulter ME, Barton AR, Kwon M et al (2018) Aging and neurodegeneration are associated with increased mutations in single human neurons. Science 359(6375):555\u2013559. https:\/\/doi.org\/10.1126\/science.aao4426","journal-title":"Science"},{"issue":"1","key":"3986_CR76","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1186\/s13059-019-1919-5","volume":"20","author":"PE Garcia-Nieto","year":"2019","unstructured":"Garcia-Nieto PE, Morrison AJ, Fraser HB (2019) The somatic mutation landscape of the human body. Genome Biol 20(1):298. https:\/\/doi.org\/10.1186\/s13059-019-1919-5","journal-title":"Genome Biol"},{"issue":"12","key":"3986_CR77","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1093\/hmg\/ddh134","volume":"13","author":"JA Beck","year":"2004","unstructured":"Beck JA, Poulter M, Campbell TA, Uphill JB, Adamson G, Geddes JF et al (2004) Somatic and germline mosaicism in sporadic early-onset Alzheimer\u2019s disease. Hum Mol Genet 13(12):1219\u20131224. https:\/\/doi.org\/10.1093\/hmg\/ddh134","journal-title":"Hum Mol Genet"},{"issue":"9","key":"3986_CR78","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1038\/mp.2015.100","volume":"20","author":"A Rovelet-Lecrux","year":"2015","unstructured":"Rovelet-Lecrux A, Charbonnier C, Wallon D, Nicolas G, Seaman MN, Pottier C et al (2015) De novo deleterious genetic variations target a biological network centered on Abeta peptide in early-onset Alzheimer disease. Mol Psychiatry 20(9):1046\u20131056. https:\/\/doi.org\/10.1038\/mp.2015.100","journal-title":"Mol Psychiatry"},{"key":"3986_CR79","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.05116","author":"DM Bushman","year":"2015","unstructured":"Bushman DM, Kaeser GE, Siddoway B, Westra JW, Rivera RR, Rehen SK et al (2015) Genomic mosaicism with increased amyloid precursor protein (APP) gene copy number in single neurons from sporadic Alzheimer\u2019s disease brains. Elife. https:\/\/doi.org\/10.7554\/eLife.05116","journal-title":"Elife"},{"issue":"11","key":"3986_CR80","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1016\/j.jalz.2015.02.007","volume":"11","author":"C Sala Frigerio","year":"2015","unstructured":"Sala Frigerio C, Lau P, Troakes C, Deramecourt V, Gele P, Van Loo P et al (2015) On the identification of low allele frequency mosaic mutations in the brains of Alzheimer\u2019s disease patients. Alzheimers Dement 11(11):1265\u20131276. https:\/\/doi.org\/10.1016\/j.jalz.2015.02.007","journal-title":"Alzheimers Dement"},{"issue":"7733","key":"3986_CR81","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/s41586-018-0718-6","volume":"563","author":"MH Lee","year":"2018","unstructured":"Lee MH, Siddoway B, Kaeser GE, Segota I, Rivera R, Romanow WJ et al (2018) Somatic APP gene recombination in Alzheimer\u2019s disease and normal neurons. Nature 563(7733):639\u2013645. https:\/\/doi.org\/10.1038\/s41586-018-0718-6","journal-title":"Nature"},{"issue":"4","key":"3986_CR82","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.3233\/JAD-140891","volume":"42","author":"A Parcerisas","year":"2014","unstructured":"Parcerisas A, Rubio SE, Muhaisen A, Gomez-Ramos A, Pujadas L, Puiggros M et al (2014) Somatic signature of brain-specific single nucleotide variations in sporadic Alzheimer\u2019s disease. J Alzheimers Dis 42(4):1357\u20131382. https:\/\/doi.org\/10.3233\/JAD-140891","journal-title":"J Alzheimers Dis"},{"issue":"4","key":"3986_CR83","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1038\/s41436-018-0274-3","volume":"21","author":"W Wei","year":"2019","unstructured":"Wei W, Keogh MJ, Aryaman J, Golder Z, Kullar PJ, Wilson I et al (2019) Frequency and signature of somatic variants in 1461 human brain exomes. Genet Med 21(4):904\u2013912. https:\/\/doi.org\/10.1038\/s41436-018-0274-3","journal-title":"Genet Med"},{"issue":"1","key":"3986_CR84","doi-asserted-by":"publisher","first-page":"3090","DOI":"10.1038\/s41467-019-11000-7","volume":"10","author":"JS Park","year":"2019","unstructured":"Park JS, Lee J, Jung ES, Kim MH, Kim IB, Son H et al (2019) Brain somatic mutations observed in Alzheimer\u2019s disease associated with aging and dysregulation of tau phosphorylation. Nat Commun 10(1):3090. https:\/\/doi.org\/10.1038\/s41467-019-11000-7","journal-title":"Nat Commun"},{"issue":"1","key":"3986_CR85","doi-asserted-by":"publisher","first-page":"4257","DOI":"10.1038\/s41467-018-06331-w","volume":"9","author":"MJ Keogh","year":"2018","unstructured":"Keogh MJ, Wei W, Aryaman J, Walker L, van den Ameele J, Coxhead J et al (2018) High prevalence of focal and multi-focal somatic genetic variants in the human brain. Nat Commun 9(1):4257. https:\/\/doi.org\/10.1038\/s41467-018-06331-w","journal-title":"Nat Commun"},{"issue":"12","key":"3986_CR86","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1016\/j.jalz.2018.06.3056","volume":"14","author":"G Nicolas","year":"2018","unstructured":"Nicolas G, Acuna-Hidalgo R, Keogh MJ, Quenez O, Steehouwer M, Lelieveld S et al (2018) Somatic variants in autosomal dominant genes are a rare cause of sporadic Alzheimer\u2019s disease. Alzheimers Dement 14(12):1632\u20131639. https:\/\/doi.org\/10.1016\/j.jalz.2018.06.3056","journal-title":"Alzheimers Dement"},{"issue":"16","key":"3986_CR87","doi-asserted-by":"publisher","first-page":"2675","DOI":"10.1093\/hmg\/ddz085","volume":"28","author":"HT Helgadottir","year":"2019","unstructured":"Helgadottir HT, Lundin P, Wallen Arzt E, Lindstrom AK, Graff C, Eriksson M (2019) Somatic mutation that affects transcription factor binding upstream of CD55 in the temporal cortex of a late-onset Alzheimer disease patient. Hum Mol Genet 28(16):2675\u20132685. https:\/\/doi.org\/10.1093\/hmg\/ddz085","journal-title":"Hum Mol Genet"},{"issue":"R2","key":"3986_CR88","doi-asserted-by":"publisher","first-page":"R197","DOI":"10.1093\/hmg\/ddz191","volume":"28","author":"MA Lodato","year":"2019","unstructured":"Lodato MA, Walsh CA (2019) Genome aging: somatic mutation in the brain links age-related decline with disease and nominates pathogenic mechanisms. Hum Mol Genet 28(R2):R197\u2013R206. https:\/\/doi.org\/10.1093\/hmg\/ddz191","journal-title":"Hum Mol Genet"},{"issue":"8","key":"3986_CR89","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/nrneurol.2015.119","volume":"11","author":"JM Tarasoff-Conway","year":"2015","unstructured":"Tarasoff-Conway JM, Carare RO, Osorio RS, Glodzik L, Butler T, Fieremans E et al (2015) Clearance systems in the brain-implications for Alzheimer disease. Nat Rev Neurol 11(8):457\u2013470. https:\/\/doi.org\/10.1038\/nrneurol.2015.119","journal-title":"Nat Rev Neurol"},{"issue":"8","key":"3986_CR90","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1038\/nn.4587","volume":"20","author":"KL Huang","year":"2017","unstructured":"Huang KL, Marcora E, Pimenova AA, Di Narzo AF, Kapoor M, Jin SC et al (2017) A common haplotype lowers PU.1 expression in myeloid cells and delays onset of Alzheimer\u2019s disease. Nat Neurosci 20(8):1052\u20131061. https:\/\/doi.org\/10.1038\/nn.4587","journal-title":"Nat Neurosci"},{"issue":"3","key":"3986_CR91","doi-asserted-by":"publisher","first-page":"e10606","DOI":"10.15252\/emmm.201910606","volume":"12","author":"A Sierksma","year":"2020","unstructured":"Sierksma A, Lu A, Mancuso R, Fattorelli N, Thrupp N, Salta E et al (2020) Novel Alzheimer risk genes determine the microglia response to amyloid-beta but not to TAU pathology. EMBO Mol Med 12(3):e10606. https:\/\/doi.org\/10.15252\/emmm.201910606","journal-title":"EMBO Mol Med"},{"key":"3986_CR92","doi-asserted-by":"publisher","first-page":"105217","DOI":"10.1016\/j.nbd.2020.105217","volume":"148","author":"AA Pimenova","year":"2021","unstructured":"Pimenova AA, Herbinet M, Gupta I, Machlovi SI, Bowles KR, Marcora E et al (2021) Alzheimer\u2019s-associated PU.1 expression levels regulate microglial inflammatory response. Neurobiol Dis 148:105217. https:\/\/doi.org\/10.1016\/j.nbd.2020.105217","journal-title":"Neurobiol Dis"},{"issue":"1","key":"3986_CR93","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1038\/s41467-021-21823-y","volume":"12","author":"G Novikova","year":"2021","unstructured":"Novikova G, Kapoor M, Tcw J, Abud EM, Efthymiou AG, Chen SX et al (2021) Integration of Alzheimer\u2019s disease genetics and myeloid genomics identifies disease risk regulatory elements and genes. Nat Commun 12(1):1610. https:\/\/doi.org\/10.1038\/s41467-021-21823-y","journal-title":"Nat Commun"},{"issue":"1","key":"3986_CR94","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1111\/imr.12896","volume":"297","author":"HE Ennerfelt","year":"2020","unstructured":"Ennerfelt HE, Lukens JR (2020) The role of innate immunity in Alzheimer\u2019s disease. Immunol Rev 297(1):225\u2013246. https:\/\/doi.org\/10.1111\/imr.12896","journal-title":"Immunol Rev"},{"issue":"12","key":"3986_CR95","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1016\/j.tins.2020.10.002","volume":"43","author":"A Podlesny-Drabiniok","year":"2020","unstructured":"Podlesny-Drabiniok A, Marcora E, Goate AM (2020) Microglial phagocytosis: a disease-associated process emerging from Alzheimer\u2019s disease genetics. Trends Neurosci 43(12):965\u2013979. https:\/\/doi.org\/10.1016\/j.tins.2020.10.002","journal-title":"Trends Neurosci"},{"issue":"S3","key":"3986_CR96","doi-asserted-by":"publisher","first-page":"e044120","DOI":"10.1002\/alz.044120","volume":"16","author":"KP Daily","year":"2020","unstructured":"Daily KP, Amer A (2020) Microglial autophagy-mediated clearance of amyloid-beta plaques is dysfunctional in Alzheimer\u2019s disease mice. Alzheimers Dement 16(S3):e044120. https:\/\/doi.org\/10.1002\/alz.044120","journal-title":"Alzheimers Dement"},{"key":"3986_CR97","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2018.00004","author":"MS Uddin","year":"2018","unstructured":"Uddin MS, Stachowiak A, Mamun AA, Tzvetkov NT, Takeda S, Atanasov AG et al (2018) Autophagy and Alzheimer\u2019s disease: from molecular mechanisms to therapeutic implications. Front Aging Neurosci. https:\/\/doi.org\/10.3389\/fnagi.2018.00004","journal-title":"Front Aging Neurosci"},{"issue":"1","key":"3986_CR98","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s13024-015-0001-3","volume":"10","author":"J Hu","year":"2015","unstructured":"Hu J, Liu CC, Chen XF, Zhang YW, Xu H, Bu G (2015) Opposing effects of viral mediated brain expression of apolipoprotein E2 (apoE2) and apoE4 on apoE lipidation and Abeta metabolism in apoE4-targeted replacement mice. Mol Neurodegener 10(1):6. https:\/\/doi.org\/10.1186\/s13024-015-0001-3","journal-title":"Mol Neurodegener"},{"issue":"3","key":"3986_CR99","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1002\/alz.12194","volume":"17","author":"DL Kober","year":"2021","unstructured":"Kober DL, Stuchell-Brereton MD, Kluender CE, Dean HB, Strickland MR, Steinberg DF et al (2021) Functional insights from biophysical study of TREM2 interactions with apoE and A\u03b21-42. Alzheimers Dement 17(3):475\u2013488. https:\/\/doi.org\/10.1002\/alz.12194","journal-title":"Alzheimers Dement"},{"issue":"4","key":"3986_CR100","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1084\/jem.20171265","volume":"215","author":"JD Ulrich","year":"2018","unstructured":"Ulrich JD, Ulland TK, Mahan TE, Nystrom S, Nilsson KP, Song WM et al (2018) ApoE facilitates the microglial response to amyloid plaque pathology. J Exp Med 215(4):1047\u20131058. https:\/\/doi.org\/10.1084\/jem.20171265","journal-title":"J Exp Med"},{"issue":"6","key":"3986_CR101","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1016\/j.neuron.2018.05.008","volume":"98","author":"YT Lin","year":"2018","unstructured":"Lin YT, Seo J, Gao F, Feldman HM, Wen HL, Penney J et al (2018) APOE4 causes widespread molecular and cellular alterations associated with Alzheimer\u2019s disease phenotypes in human iPSC-derived brain cell types. Neuron 98(6):1141-1154 e1147. https:\/\/doi.org\/10.1016\/j.neuron.2018.05.008","journal-title":"Neuron"},{"issue":"16","key":"3986_CR102","doi-asserted-by":"publisher","first-page":"10843","DOI":"10.1073\/pnas.162228299","volume":"99","author":"RB DeMattos","year":"2002","unstructured":"DeMattos RB, O\u2019Dell MA, Parsadanian M, Taylor JW, Harmony JA, Bales KR et al (2002) Clusterin promotes amyloid plaque formation and is critical for neuritic toxicity in a mouse model of Alzheimer\u2019s disease. Proc Natl Acad Sci USA 99(16):10843\u201310848. https:\/\/doi.org\/10.1073\/pnas.162228299","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"3986_CR103","doi-asserted-by":"publisher","first-page":"5775","DOI":"10.1038\/ncomms6775","volume":"5","author":"F Zhang","year":"2014","unstructured":"Zhang F, Kumano M, Beraldi E, Fazli L, Du C, Moore S et al (2014) Clusterin facilitates stress-induced lipidation of LC3 and autophagosome biogenesis to enhance cancer cell survival. Nat Commun 5(1):5775. https:\/\/doi.org\/10.1038\/ncomms6775","journal-title":"Nat Commun"},{"issue":"2","key":"3986_CR104","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.neuron.2016.06.015","volume":"91","author":"FL Yeh","year":"2016","unstructured":"Yeh FL, Wang Y, Tom I, Gonzalez LC, Sheng M (2016) TREM2 binds to apolipoproteins, including APOE and CLU\/APOJ, and thereby facilitates uptake of amyloid-beta by microglia. Neuron 91(2):328\u2013340. https:\/\/doi.org\/10.1016\/j.neuron.2016.06.015","journal-title":"Neuron"},{"issue":"5","key":"3986_CR105","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/j.neuron.2018.01.031","volume":"97","author":"Y Zhao","year":"2018","unstructured":"Zhao Y, Wu X, Li X, Jiang LL, Gui X, Liu Y et al (2018) TREM2 is a receptor for \u03b2-amyloid that mediates microglial function. Neuron 97(5):1023-1031.e1027. https:\/\/doi.org\/10.1016\/j.neuron.2018.01.031","journal-title":"Neuron"},{"key":"3986_CR106","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.201809027","author":"CB Lessard","year":"2018","unstructured":"Lessard CB, Malnik SL, Zhou Y, Ladd TB, Cruz PE, Ran Y et al (2018) High-affinity interactions and signal transduction between A\u03b2 oligomers and TREM2. EMBO Mol Med. https:\/\/doi.org\/10.15252\/emmm.201809027","journal-title":"EMBO Mol Med"},{"issue":"18","key":"3986_CR107","doi-asserted-by":"publisher","first-page":"3515","DOI":"10.1111\/bph.14618","volume":"176","author":"S Nizami","year":"2019","unstructured":"Nizami S, Hall-Roberts H, Warrier S, Cowley SA, Di Daniel E (2019) Microglial inflammation and phagocytosis in Alzheimer\u2019s disease: potential therapeutic targets. Br J Pharmacol 176(18):3515\u20133532. https:\/\/doi.org\/10.1111\/bph.14618","journal-title":"Br J Pharmacol"},{"issue":"2","key":"3986_CR108","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1007\/s40200-020-00588-z","volume":"19","author":"SZ Al-Fadhel","year":"2020","unstructured":"Al-Fadhel SZ, Al-Ghuraibawi NHA, Mohammed Ali DM, Al-Hakeim HK (2020) Serum cytokine dependent hematopoietic cell linker (CLNK) as a predictor for the duration of illness in type 2 diabetes mellitus. J Diabetes Metab Disord 19(2):959\u2013966. https:\/\/doi.org\/10.1007\/s40200-020-00588-z","journal-title":"J Diabetes Metab Disord"},{"issue":"3","key":"3986_CR109","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1084\/jem.20171529","volume":"215","author":"WM Song","year":"2018","unstructured":"Song WM, Joshita S, Zhou Y, Ulland TK, Gilfillan S, Colonna M (2018) Humanized TREM2 mice reveal microglia-intrinsic and -extrinsic effects of R47H polymorphism. J Exp Med 215(3):745\u2013760. https:\/\/doi.org\/10.1084\/jem.20171529","journal-title":"J Exp Med"},{"issue":"1","key":"3986_CR110","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.neuron.2016.09.016","volume":"92","author":"P Yuan","year":"2016","unstructured":"Yuan P, Condello C, Keene CD, Wang Y, Bird TD, Paul SM et al (2016) TREM2 haplodeficiency in mice and humans impairs the microglia barrier function leading to decreased amyloid compaction and severe axonal dystrophy. Neuron 92(1):252\u2013264. https:\/\/doi.org\/10.1016\/j.neuron.2016.09.016","journal-title":"Neuron"},{"issue":"6","key":"3986_CR111","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1007\/s00401-020-02138-6","volume":"139","author":"L Kleineidam","year":"2020","unstructured":"Kleineidam L, Chouraki V, Prochnicki T, van der Lee SJ, Madrid-Marquez L, Wagner-Thelen H et al (2020) PLCG2 protective variant p.P522R modulates tau pathology and disease progression in patients with mild cognitive impairment. Acta Neuropathol 139(6):1025\u20131044. https:\/\/doi.org\/10.1007\/s00401-020-02138-6","journal-title":"Acta Neuropathol"},{"issue":"10","key":"3986_CR112","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.15252\/emmm.201707672","volume":"9","author":"K Schlepckow","year":"2017","unstructured":"Schlepckow K, Kleinberger G, Fukumori A, Feederle R, Lichtenthaler SF, Steiner H et al (2017) An Alzheimer-associated TREM2 variant occurs at the ADAM cleavage site and affects shedding and phagocytic function. EMBO Mol Med 9(10):1356\u20131365. https:\/\/doi.org\/10.15252\/emmm.201707672","journal-title":"EMBO Mol Med"},{"issue":"4","key":"3986_CR113","doi-asserted-by":"publisher","first-page":"318","DOI":"10.2174\/1567202613666160808095530","volume":"13","author":"T Jiang","year":"2016","unstructured":"Jiang T, Hou JK, Gao Q, Yu JT, Zhou JS, Zhao HD et al (2016) TREM2 p.H157Y variant and the risk of Alzheimer\u2019s disease: a meta-analysis involving 14,510 subjects. Curr Neurovasc Res 13(4):318\u2013320. https:\/\/doi.org\/10.2174\/1567202613666160808095530","journal-title":"Curr Neurovasc Res"},{"issue":"4","key":"3986_CR114","doi-asserted-by":"publisher","first-page":"347","DOI":"10.3892\/etm.2021.9778","volume":"21","author":"R Li","year":"2021","unstructured":"Li R, Wang X, He P (2021) The most prevalent rare coding variants of TREM2 conferring risk of Alzheimer\u2019s disease: a systematic review and meta-analysis. Exp Ther Med 21(4):347. https:\/\/doi.org\/10.3892\/etm.2021.9778","journal-title":"Exp Ther Med"},{"key":"3986_CR115","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aau2291","author":"Y Deming","year":"2019","unstructured":"Deming Y, Filipello F, Cignarella F, Cantoni C, Hsu S, Mikesell R et al (2019) The MS4A gene cluster is a key modulator of soluble TREM2 and Alzheimer\u2019s disease risk. Sci Transl Med. https:\/\/doi.org\/10.1126\/scitranslmed.aau2291","journal-title":"Sci Transl Med"},{"issue":"4","key":"3986_CR116","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1159\/000492596","volume":"65","author":"L Zhao","year":"2019","unstructured":"Zhao L (2019) CD33 in Alzheimer\u2019s disease - biology, pathogenesis, and therapeutics: a mini-review. Gerontology 65(4):323\u2013331. https:\/\/doi.org\/10.1159\/000492596","journal-title":"Gerontology"},{"issue":"1","key":"3986_CR117","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s13024-021-00443-6","volume":"16","author":"A Bhattacherjee","year":"2021","unstructured":"Bhattacherjee A, Jung J, Zia S, Ho M, Eskandari-Sedighi G, St. Laurent CD et al (2021) The CD33 short isoform is a gain-of-function variant that enhances A\u03b21\u201342 phagocytosis in microglia. Mol Neurodegener 16(1):19. https:\/\/doi.org\/10.1186\/s13024-021-00443-6","journal-title":"Mol Neurodegener"},{"issue":"37","key":"3986_CR118","doi-asserted-by":"publisher","first-page":"15312","DOI":"10.1074\/jbc.M117.799346","volume":"292","author":"SS Siddiqui","year":"2017","unstructured":"Siddiqui SS, Springer SA, Verhagen A, Sundaramurthy V, Alisson-Silva F, Jiang W et al (2017) The Alzheimer\u2019s disease-protective CD33 splice variant mediates adaptive loss of function via diversion to an intracellular pool. J Biol Chem 292(37):15312\u201315320. https:\/\/doi.org\/10.1074\/jbc.M117.799346","journal-title":"J Biol Chem"},{"issue":"1","key":"3986_CR119","doi-asserted-by":"publisher","first-page":"fcz022","DOI":"10.1093\/braincomms\/fcz022","volume":"1","author":"DA Salih","year":"2019","unstructured":"Salih DA, Bayram S, Guelfi S, Reynolds RH, Shoai M, Ryten M et al (2019) Genetic variability in response to amyloid beta deposition influences Alzheimer\u2019s disease risk. Brain Commun 1(1):fcz022. https:\/\/doi.org\/10.1093\/braincomms\/fcz022","journal-title":"Brain Commun"},{"issue":"11","key":"3986_CR120","doi-asserted-by":"publisher","first-page":"e1007427","DOI":"10.1371\/journal.pgen.1007427","volume":"14","author":"N Rathore","year":"2018","unstructured":"Rathore N, Ramani SR, Pantua H, Payandeh J, Bhangale T, Wuster A et al (2018) Paired Immunoglobulin-like Type 2 Receptor Alpha G78R variant alters ligand binding and confers protection to Alzheimer\u2019s disease. PLoS Genet 14(11):e1007427. https:\/\/doi.org\/10.1371\/journal.pgen.1007427","journal-title":"PLoS Genet"},{"issue":"S3","key":"3986_CR121","doi-asserted-by":"publisher","first-page":"e045988","DOI":"10.1002\/alz.045988","volume":"16","author":"J Miller","year":"2020","unstructured":"Miller J, McKinnon L, Murcia JDG, Kauwe J, Ridge PG (2020) Synonymous variant rs2405442 in PILRA is associated with Alzheimer\u2019s disease and affects RNA expression by destroying a ramp sequence. Alzheimers Dement 16(S3):e045988. https:\/\/doi.org\/10.1002\/alz.045988","journal-title":"Alzheimers Dement"},{"issue":"8","key":"3986_CR122","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1007\/s10571-019-00712-5","volume":"39","author":"S Agostini","year":"2019","unstructured":"Agostini S, Costa AS, Mancuso R, Guerini FR, Nemni R, Clerici M (2019) The PILRA G78R variant correlates with higher HSV-1-specific IgG titers in Alzheimer\u2019s disease. Cell Mol Neurobiol 39(8):1217\u20131221. https:\/\/doi.org\/10.1007\/s10571-019-00712-5","journal-title":"Cell Mol Neurobiol"},{"issue":"2","key":"3986_CR123","doi-asserted-by":"publisher","first-page":"e0149792","DOI":"10.1371\/journal.pone.0149792","volume":"11","author":"MI Fonseca","year":"2016","unstructured":"Fonseca MI, Chu S, Pierce AL, Brubaker WD, Hauhart RE, Mastroeni D et al (2016) Analysis of the putative role of CR1 in Alzheimer\u2019s disease: genetic association, expression and function. PLoS ONE 11(2):e0149792. https:\/\/doi.org\/10.1371\/journal.pone.0149792","journal-title":"PLoS ONE"},{"issue":"4","key":"3986_CR124","doi-asserted-by":"publisher","first-page":"1766 e1765","DOI":"10.1016\/j.neurobiolaging.2015.01.006","volume":"36","author":"R Mahmoudi","year":"2015","unstructured":"Mahmoudi R, Kisserli A, Novella JL, Donvito B, Drame M, Reveil B et al (2015) Alzheimer\u2019s disease is associated with low density of the long CR1 isoform. Neurobiol Aging 36(4):1766 e1765-1766 e1712. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2015.01.006","journal-title":"Neurobiol Aging"},{"issue":"2","key":"3986_CR125","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/mp.2011.24","volume":"17","author":"N Brouwers","year":"2012","unstructured":"Brouwers N, Van Cauwenberghe C, Engelborghs S, Lambert JC, Bettens K, Le Bastard N et al (2012) Alzheimer risk associated with a copy number variation in the complement receptor 1 increasing C3b\/C4b binding sites. Mol Psychiatry 17(2):223\u2013233. https:\/\/doi.org\/10.1038\/mp.2011.24","journal-title":"Mol Psychiatry"},{"issue":"38","key":"3986_CR126","doi-asserted-by":"publisher","first-page":"11982","DOI":"10.1523\/JNEUROSCI.3158-09.2009","volume":"29","author":"EG Reed-Geaghan","year":"2009","unstructured":"Reed-Geaghan EG, Savage JC, Hise AG, Landreth GE (2009) CD14 and toll-like receptors 2 and 4 are required for fibrillar Abeta-stimulated microglial activation. J Neurosci 29(38):11982\u201311992. https:\/\/doi.org\/10.1523\/JNEUROSCI.3158-09.2009","journal-title":"J Neurosci"},{"issue":"3","key":"3986_CR127","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.neulet.2005.08.047","volume":"391","author":"P Minoretti","year":"2006","unstructured":"Minoretti P, Gazzaruso C, Vito CD, Emanuele E, Bianchi M, Coen E et al (2006) Effect of the functional toll-like receptor 4 Asp299Gly polymorphism on susceptibility to late-onset Alzheimer\u2019s disease. Neurosci Lett 391(3):147\u2013149. https:\/\/doi.org\/10.1016\/j.neulet.2005.08.047","journal-title":"Neurosci Lett"},{"issue":"7","key":"3986_CR128","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1016\/j.jalz.2019.03.012","volume":"15","author":"J Miron","year":"2019","unstructured":"Miron J, Picard C, Lafaille-Magnan M, Savard M, Labont\u00e9 A, Breitner J et al (2019) Association of TLR4 with Alzheimer\u2019s disease risk and presymptomatic biomarkers of inflammation. Alzheimers Dement 15(7):951\u2013960. https:\/\/doi.org\/10.1016\/j.jalz.2019.03.012","journal-title":"Alzheimers Dement"},{"issue":"461","key":"3986_CR129","doi-asserted-by":"publisher","first-page":"461","DOI":"10.3389\/fimmu.2014.00461","volume":"5","author":"T Kawasaki","year":"2014","unstructured":"Kawasaki T, Kawai T (2014) Toll-like receptor signaling pathways. Front Immunol 5(461):461. https:\/\/doi.org\/10.3389\/fimmu.2014.00461","journal-title":"Front Immunol"},{"issue":"2","key":"3986_CR130","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1002\/JLB.2MA0819-138RR","volume":"107","author":"L Luo","year":"2020","unstructured":"Luo L, Curson JEB, Liu L, Wall AA, Tuladhar N, Lucas RM et al (2020) SCIMP is a universal Toll-like receptor adaptor in macrophages. J Leukoc Biol 107(2):251\u2013262. https:\/\/doi.org\/10.1002\/JLB.2MA0819-138RR","journal-title":"J Leukoc Biol"},{"issue":"1","key":"3986_CR131","doi-asserted-by":"publisher","first-page":"14133","DOI":"10.1038\/ncomms14133","volume":"8","author":"L Luo","year":"2017","unstructured":"Luo L, Bokil NJ, Wall AA, Kapetanovic R, Lansdaal NM, Marceline F et al (2017) SCIMP is a transmembrane non-TIR TLR adaptor that promotes proinflammatory cytokine production from macrophages. Nat Commun 8(1):14133. https:\/\/doi.org\/10.1038\/ncomms14133","journal-title":"Nat Commun"},{"issue":"7","key":"3986_CR132","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1038\/cdd.2017.17","volume":"24","author":"P Cohen","year":"2017","unstructured":"Cohen P, Strickson S (2017) The role of hybrid ubiquitin chains in the MyD88 and other innate immune signalling pathways. Cell Death Differ 24(7):1153\u20131159. https:\/\/doi.org\/10.1038\/cdd.2017.17","journal-title":"Cell Death Differ"},{"issue":"7","key":"3986_CR133","doi-asserted-by":"publisher","first-page":"486","DOI":"10.18632\/oncoscience.64","volume":"1","author":"TN Beck","year":"2014","unstructured":"Beck TN, Nicolas E, Kopp MC, Golemis EA (2014) Adaptors for disorders of the brain? The cancer signaling proteins NEDD9, CASS4, and PTK2B in Alzheimer\u2019s disease. Oncoscience 1(7):486\u2013503. https:\/\/doi.org\/10.18632\/oncoscience.64","journal-title":"Oncoscience"},{"issue":"11","key":"3986_CR134","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1038\/s41588-018-0238-1","volume":"50","author":"T Raj","year":"2018","unstructured":"Raj T, Li YI, Wong G, Humphrey J, Wang M, Ramdhani S et al (2018) Integrative transcriptome analyses of the aging brain implicate altered splicing in Alzheimer\u2019s disease susceptibility. Nat Genet 50(11):1584\u20131592. https:\/\/doi.org\/10.1038\/s41588-018-0238-1","journal-title":"Nat Genet"},{"issue":"1","key":"3986_CR135","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s13024-018-0282-4","volume":"13","author":"ECB Johnson","year":"2018","unstructured":"Johnson ECB, Dammer EB, Duong DM, Yin L, Thambisetty M, Troncoso JC et al (2018) Deep proteomic network analysis of Alzheimer\u2019s disease brain reveals alterations in RNA binding proteins and RNA splicing associated with disease. Mol Neurodegener 13(1):52. https:\/\/doi.org\/10.1186\/s13024-018-0282-4","journal-title":"Mol Neurodegener"},{"issue":"1","key":"3986_CR136","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s13024-018-0289-x","volume":"13","author":"OJ Conway","year":"2018","unstructured":"Conway OJ, Carrasquillo MM, Wang X, Bredenberg JM, Reddy JS, Strickland SL et al (2018) ABI3 and PLCG2 missense variants as risk factors for neurodegenerative diseases in Caucasians and African Americans. Mol Neurodegener 13(1):53. https:\/\/doi.org\/10.1186\/s13024-018-0289-x","journal-title":"Mol Neurodegener"},{"issue":"4","key":"3986_CR137","doi-asserted-by":"publisher","first-page":"262","DOI":"10.5582\/irdr.2017.01073","volume":"6","author":"JI Satoh","year":"2017","unstructured":"Satoh JI, Kino Y, Yanaizu M, Tosaki Y, Sakai K, Ishida T et al (2017) Microglia express ABI3 in the brains of Alzheimer\u2019s disease and Nasu-Hakola disease. Intractable Rare Dis Res 6(4):262\u2013268. https:\/\/doi.org\/10.5582\/irdr.2017.01073","journal-title":"Intractable Rare Dis Res"},{"key":"3986_CR138","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.matbio.2018.01.003","volume":"68\u201369","author":"M Yasuda-Yamahara","year":"2018","unstructured":"Yasuda-Yamahara M, Rogg M, Frimmel J, Trachte P, Helmstaedter M, Schroder P et al (2018) FERMT2 links cortical actin structures, plasma membrane tension and focal adhesion function to stabilize podocyte morphology. Matrix Biol J Int Soc Matrix Biol 68\u201369:263\u2013279. https:\/\/doi.org\/10.1016\/j.matbio.2018.01.003","journal-title":"Matrix Biol J Int Soc Matrix Biol"},{"issue":"26","key":"3986_CR139","doi-asserted-by":"publisher","first-page":"18236","DOI":"10.1074\/jbc.M512917200","volume":"281","author":"S Frese","year":"2006","unstructured":"Frese S, Schubert WD, Findeis AC, Marquardt T, Roske YS, Stradal TE et al (2006) The phosphotyrosine peptide binding specificity of Nck1 and Nck2 Src homology 2 domains. J Biol Chem 281(26):18236\u201318245. https:\/\/doi.org\/10.1074\/jbc.M512917200","journal-title":"J Biol Chem"},{"issue":"1","key":"3986_CR140","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s40035-020-00206-1","volume":"9","author":"R Shen","year":"2020","unstructured":"Shen R, Zhao X, He L, Ding Y, Xu W, Lin S et al (2020) Upregulation of RIN3 induces endosomal dysfunction in Alzheimer\u2019s disease. Transl Neurodegener 9(1):26. https:\/\/doi.org\/10.1186\/s40035-020-00206-1","journal-title":"Transl Neurodegener"},{"issue":"1","key":"3986_CR141","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/s13073-017-0486-1","volume":"9","author":"PG Ridge","year":"2017","unstructured":"Ridge PG, Karch CM, Hsu S, Arano I, Teerlink CC, Ebbert MTW et al (2017) Linkage, whole genome sequence, and biological data implicate variants in RAB10 in Alzheimer\u2019s disease resilience. Genome Med 9(1):100. https:\/\/doi.org\/10.1186\/s13073-017-0486-1","journal-title":"Genome Med"},{"issue":"1","key":"3986_CR142","doi-asserted-by":"publisher","first-page":"3958","DOI":"10.1038\/s41467-018-06172-7","volume":"9","author":"AK Davies","year":"2018","unstructured":"Davies AK, Itzhak DN, Edgar JR, Archuleta TL, Hirst J, Jackson LP et al (2018) AP-4 vesicles contribute to spatial control of autophagy via RUSC-dependent peripheral delivery of ATG9A. Nat Commun 9(1):3958. https:\/\/doi.org\/10.1038\/s41467-018-06172-7","journal-title":"Nat Commun"},{"key":"3986_CR143","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.2741\/4546","volume":"22","author":"MP Cuajungco","year":"2017","unstructured":"Cuajungco MP, Kiselyov K (2017) The mucolipin-1 (TRPML1) ion channel, transmembrane-163 (TMEM163) protein, and lysosomal zinc handling. Front Biosci (Landmark Ed) 22:1330\u20131343. https:\/\/doi.org\/10.2741\/4546","journal-title":"Front Biosci (Landmark Ed)"},{"issue":"9","key":"3986_CR144","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1002\/glia.23641","volume":"67","author":"LE Kuil","year":"2019","unstructured":"Kuil LE, Lopez Marti A, Carreras Mascaro A, van den Bosch JC, van den Berg P, van der Linde HC et al (2019) Hexb enzyme deficiency leads to lysosomal abnormalities in radial glia and microglia in zebrafish brain development. Glia 67(9):1705\u20131718. https:\/\/doi.org\/10.1002\/glia.23641","journal-title":"Glia"},{"issue":"1","key":"3986_CR145","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1111\/cge.13224","volume":"94","author":"E Poletto","year":"2018","unstructured":"Poletto E, Pasqualim G, Giugliani R, Matte U, Baldo G (2018) Worldwide distribution of common IDUA pathogenic variants. Clin Genet 94(1):95\u2013102. https:\/\/doi.org\/10.1111\/cge.13224","journal-title":"Clin Genet"},{"key":"3986_CR146","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/j.biopha.2018.05.148","volume":"105","author":"S Patel","year":"2018","unstructured":"Patel S, Homaei A, El-Seedi HR, Akhtar N (2018) Cathepsins: Proteases that are vital for survival but can also be fatal. Biomed Pharmacother 105:526\u2013532. https:\/\/doi.org\/10.1016\/j.biopha.2018.05.148","journal-title":"Biomed Pharmacother"},{"issue":"21","key":"3986_CR147","doi-asserted-by":"publisher","first-page":"3981","DOI":"10.1128\/mcb.00113-14","volume":"34","author":"M Ruas","year":"2014","unstructured":"Ruas M, Chuang KT, Davis LC, Al-Douri A, Tynan PW, Tunn R et al (2014) TPC1 has two variant isoforms, and their removal has different effects on endo-lysosomal functions compared to loss of TPC2. Mol Cell Biol 34(21):3981\u20133992. https:\/\/doi.org\/10.1128\/mcb.00113-14","journal-title":"Mol Cell Biol"},{"issue":"10","key":"3986_CR148","doi-asserted-by":"publisher","first-page":"e50219","DOI":"10.15252\/embr.202050219","volume":"21","author":"T Feng","year":"2020","unstructured":"Feng T, Mai S, Roscoe JM, Sheng RR, Ullah M, Zhang J et al (2020) Loss of TMEM106B and PGRN leads to severe lysosomal abnormalities and neurodegeneration in mice. EMBO Rep 21(10):e50219. https:\/\/doi.org\/10.15252\/embr.202050219","journal-title":"EMBO Rep"},{"key":"3986_CR149","doi-asserted-by":"publisher","DOI":"10.3390\/cells8030230","author":"A Mendsaikhan","year":"2019","unstructured":"Mendsaikhan A, Tooyama I, Walker DG (2019) Microglial progranulin: involvement in Alzheimer\u2019s disease and neurodegenerative diseases. Cells. https:\/\/doi.org\/10.3390\/cells8030230","journal-title":"Cells"},{"issue":"4","key":"3986_CR150","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1084\/jem.20181773","volume":"216","author":"W Huai","year":"2019","unstructured":"Huai W, Liu X, Wang C, Zhang Y, Chen X, Chen X et al (2019) KAT8 selectively inhibits antiviral immunity by acetylating IRF3. J Exp Med 216(4):772\u2013785. https:\/\/doi.org\/10.1084\/jem.20181773","journal-title":"J Exp Med"},{"issue":"705","key":"3986_CR151","doi-asserted-by":"publisher","first-page":"705","DOI":"10.3389\/fimmu.2019.00705","volume":"10","author":"MG Dorrington","year":"2019","unstructured":"Dorrington MG, Fraser IDC (2019) NF-kappaB signaling in macrophages: dynamics, crosstalk, and signal Integration. Front Immunol 10(705):705. https:\/\/doi.org\/10.3389\/fimmu.2019.00705","journal-title":"Front Immunol"},{"issue":"2 Suppl 2","key":"3986_CR152","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1016\/j.jaci.2009.12.980","volume":"125","author":"DD Chaplin","year":"2010","unstructured":"Chaplin DD (2010) Overview of the immune response. J Allergy Clin Immunol 125(2 Suppl 2):S3-23. https:\/\/doi.org\/10.1016\/j.jaci.2009.12.980","journal-title":"J Allergy Clin Immunol"},{"issue":"19","key":"3986_CR153","doi-asserted-by":"publisher","first-page":"3681","DOI":"10.1007\/s00018-019-03132-2","volume":"76","author":"R Das","year":"2019","unstructured":"Das R, Chinnathambi S (2019) Microglial priming of antigen presentation and adaptive stimulation in Alzheimer\u2019s disease. Cell Mol Life Sci 76(19):3681\u20133694. https:\/\/doi.org\/10.1007\/s00018-019-03132-2","journal-title":"Cell Mol Life Sci"},{"issue":"5","key":"3986_CR154","doi-asserted-by":"publisher","first-page":"e1007053","DOI":"10.1371\/journal.ppat.1007053","volume":"14","author":"S Raju","year":"2018","unstructured":"Raju S, Kometani K, Kurosaki T, Shaw AS, Egawa T (2018) The adaptor molecule CD2AP in CD4 T cells modulates differentiation of follicular helper T cells during chronic LCMV infection. PLoS Pathog 14(5):e1007053. https:\/\/doi.org\/10.1371\/journal.ppat.1007053","journal-title":"PLoS Pathog"},{"issue":"22","key":"3986_CR155","doi-asserted-by":"publisher","first-page":"4550","DOI":"10.1128\/MCB.05817-11","volume":"31","author":"P Draber","year":"2011","unstructured":"Draber P, Vonkova I, Stepanek O, Hrdinka M, Kucova M, Skopcova T et al (2011) SCIMP, a transmembrane adaptor protein involved in major histocompatibility complex class II signaling. Mol Cell Biol 31(22):4550\u20134562. https:\/\/doi.org\/10.1128\/MCB.05817-11","journal-title":"Mol Cell Biol"},{"key":"3986_CR156","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abb0457","author":"YH Liu","year":"2021","unstructured":"Liu YH, Wang J, Li QX, Fowler CJ, Zeng F, Deng J et al (2021) Association of naturally occurring antibodies to beta-amyloid with cognitive decline and cerebral amyloidosis in Alzheimer\u2019s disease. Sci Adv. https:\/\/doi.org\/10.1126\/sciadv.abb0457","journal-title":"Sci Adv"},{"issue":"7","key":"3986_CR157","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1016\/j.cell.2017.05.018","volume":"169","author":"H Keren-Shaul","year":"2017","unstructured":"Keren-Shaul H, Spinrad A, Weiner A, Matcovitch-Natan O, Dvir-Szternfeld R, Ulland TK et al (2017) A unique microglia type associated with restricting development of Alzheimer\u2019s disease. Cell 169(7):1276-1290 e1217. https:\/\/doi.org\/10.1016\/j.cell.2017.05.018","journal-title":"Cell"},{"issue":"5","key":"3986_CR158","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1016\/j.cell.2018.05.003","volume":"173","author":"A Deczkowska","year":"2018","unstructured":"Deczkowska A, Keren-Shaul H, Weiner A, Colonna M, Schwartz M, Amit I (2018) Disease-associated microglia: a universal immune sensor of neurodegeneration. Cell 173(5):1073\u20131081. https:\/\/doi.org\/10.1016\/j.cell.2018.05.003","journal-title":"Cell"},{"issue":"1","key":"3986_CR159","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.immuni.2018.11.004","volume":"50","author":"TR Hammond","year":"2019","unstructured":"Hammond TR, Dufort C, Dissing-Olesen L, Giera S, Young A, Wysoker A et al (2019) Single-cell RNA sequencing of microglia throughout the mouse lifespan and in the injured brain reveals complex cell-state changes. Immunity 50(1):253-271 e256. https:\/\/doi.org\/10.1016\/j.immuni.2018.11.004","journal-title":"Immunity"},{"issue":"3","key":"3986_CR160","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1016\/j.celrep.2017.12.066","volume":"22","author":"BA Friedman","year":"2018","unstructured":"Friedman BA, Srinivasan K, Ayalon G, Meilandt WJ, Lin H, Huntley MA et al (2018) Diverse brain myeloid expression profiles reveal distinct microglial activation states and aspects of Alzheimer\u2019s disease not evident in mouse models. Cell Rep 22(3):832\u2013847. https:\/\/doi.org\/10.1016\/j.celrep.2017.12.066","journal-title":"Cell Rep"},{"issue":"7761","key":"3986_CR161","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1038\/s41586-019-1195-2","volume":"570","author":"H Mathys","year":"2019","unstructured":"Mathys H, Davila-Velderrain J, Peng Z, Gao F, Mohammadi S, Young JZ et al (2019) Single-cell transcriptomic analysis of Alzheimer\u2019s disease. Nature 570(7761):332\u2013337. https:\/\/doi.org\/10.1038\/s41586-019-1195-2","journal-title":"Nature"},{"issue":"1","key":"3986_CR162","doi-asserted-by":"publisher","first-page":"6129","DOI":"10.1038\/s41467-020-19737-2","volume":"11","author":"M Olah","year":"2020","unstructured":"Olah M, Menon V, Habib N, Taga MF, Ma Y, Yung CJ et al (2020) Single cell RNA sequencing of human microglia uncovers a subset associated with Alzheimer\u2019s disease. Nat Commun 11(1):6129. https:\/\/doi.org\/10.1038\/s41467-020-19737-2","journal-title":"Nat Commun"},{"issue":"13","key":"3986_CR163","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.107843","volume":"31","author":"K Srinivasan","year":"2020","unstructured":"Srinivasan K, Friedman BA, Etxeberria A, Huntley MA, van der Brug MP, Foreman O et al (2020) Alzheimer\u2019s patient microglia exhibit enhanced aging and unique transcriptional activation. Cell Rep 31(13):107843. https:\/\/doi.org\/10.1016\/j.celrep.2020.107843","journal-title":"Cell Rep"},{"issue":"6","key":"3986_CR164","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1111\/bpa.12911","volume":"30","author":"D Berchtold","year":"2020","unstructured":"Berchtold D, Priller J, Meisel C, Meisel A (2020) Interaction of microglia with infiltrating immune cells in the different phases of stroke. Brain Pathol 30(6):1208\u20131218. https:\/\/doi.org\/10.1111\/bpa.12911","journal-title":"Brain Pathol"},{"key":"3986_CR165","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.expneurol.2017.11.010","volume":"300","author":"AS Harms","year":"2018","unstructured":"Harms AS, Thome AD, Yan Z, Schonhoff AM, Williams GP, Li X et al (2018) Peripheral monocyte entry is required for alpha-synuclein induced inflammation and neurodegeneration in a model of Parkinson disease. Exp Neurol 300:179\u2013187. https:\/\/doi.org\/10.1016\/j.expneurol.2017.11.010","journal-title":"Exp Neurol"},{"issue":"7858","key":"3986_CR166","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/s41586-021-03489-0","volume":"593","author":"S Da Mesquita","year":"2021","unstructured":"Da Mesquita S, Papadopoulos Z, Dykstra T, Brase L, Farias FG, Wall M et al (2021) Meningeal lymphatics affect microglia responses and anti-Abeta immunotherapy. Nature 593(7858):255\u2013260. https:\/\/doi.org\/10.1038\/s41586-021-03489-0","journal-title":"Nature"},{"issue":"10","key":"3986_CR167","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1038\/nrneurol.2017.111","volume":"13","author":"J Wang","year":"2017","unstructured":"Wang J, Gu BJ, Masters CL, Wang YJ (2017) A systemic view of Alzheimer disease - insights from amyloid-beta metabolism beyond the brain. Nat Rev Neurol 13(10):612\u2013623. https:\/\/doi.org\/10.1038\/nrneurol.2017.111","journal-title":"Nat Rev Neurol"},{"issue":"12","key":"3986_CR168","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1002\/acn3.369","volume":"3","author":"SA Gagliano","year":"2016","unstructured":"Gagliano SA, Pouget JG, Hardy J, Knight J, Barnes MR, Ryten M et al (2016) Genomics implicates adaptive and innate immunity in Alzheimer\u2019s and Parkinson\u2019s diseases. Ann Clin Transl Neurol 3(12):924\u2013933. https:\/\/doi.org\/10.1002\/acn3.369","journal-title":"Ann Clin Transl Neurol"},{"issue":"1","key":"3986_CR169","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s13073-018-0523-8","volume":"10","author":"KE Tansey","year":"2018","unstructured":"Tansey KE, Cameron D, Hill MJ (2018) Genetic risk for Alzheimer\u2019s disease is concentrated in specific macrophage and microglial transcriptional networks. Genome Med 10(1):14. https:\/\/doi.org\/10.1186\/s13073-018-0523-8","journal-title":"Genome Med"},{"key":"3986_CR170","doi-asserted-by":"publisher","first-page":"2030","DOI":"10.1038\/ncomms3030","volume":"4","author":"D Frenkel","year":"2013","unstructured":"Frenkel D, Wilkinson K, Zhao L, Hickman SE, Means TK, Puckett L et al (2013) Scara1 deficiency impairs clearance of soluble amyloid-beta by mononuclear phagocytes and accelerates Alzheimer\u2019s-like disease progression. Nat Commun 4:2030. https:\/\/doi.org\/10.1038\/ncomms3030","journal-title":"Nat Commun"},{"issue":"3","key":"3986_CR171","doi-asserted-by":"publisher","first-page":"221","DOI":"10.3233\/jad-2005-7304","volume":"7","author":"M Fiala","year":"2005","unstructured":"Fiala M, Lin J, Ringman J, Kermani-Arab V, Tsao G, Patel A et al (2005) Ineffective phagocytosis of amyloid-beta by macrophages of Alzheimer\u2019s disease patients. J Alzheimers Dis 7(3):221\u2013232. https:\/\/doi.org\/10.3233\/jad-2005-7304 (discussion 255-262)","journal-title":"J Alzheimers Dis"},{"issue":"3","key":"3986_CR172","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s00401-016-1596-3","volume":"132","author":"BJ Gu","year":"2016","unstructured":"Gu BJ, Huang X, Ou A, Rembach A, Fowler C, Avula PK et al (2016) Innate phagocytosis by peripheral blood monocytes is altered in Alzheimer\u2019s disease. Acta Neuropathol 132(3):377\u2013389. https:\/\/doi.org\/10.1007\/s00401-016-1596-3","journal-title":"Acta Neuropathol"},{"issue":"11","key":"3986_CR173","doi-asserted-by":"publisher","first-page":"2237","DOI":"10.3727\/096368915X688894","volume":"24","author":"D Darlington","year":"2015","unstructured":"Darlington D, Li S, Hou H, Habib A, Tian J, Gao Y et al (2015) Human umbilical cord blood-derived monocytes improve cognitive deficits and reduce amyloid-beta pathology in PSAPP mice. Cell Transpl 24(11):2237\u20132250. https:\/\/doi.org\/10.3727\/096368915X688894","journal-title":"Cell Transpl"},{"key":"3986_CR174","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/978-1-4614-3461-0_7","volume":"750","author":"JP Bach","year":"2012","unstructured":"Bach JP, Dodel R (2012) Naturally occurring autoantibodies against \u03b2-Amyloid. Adv Exp Med Biol 750:91\u201399. https:\/\/doi.org\/10.1007\/978-1-4614-3461-0_7","journal-title":"Adv Exp Med Biol"},{"issue":"4","key":"3986_CR175","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.biopsych.2017.08.010","volume":"83","author":"CH van Dyck","year":"2018","unstructured":"van Dyck CH (2018) Anti-amyloid-\u03b2 monoclonal antibodies for Alzheimer\u2019s disease: pitfalls and promise. Biol Psychiatry 83(4):311\u2013319. https:\/\/doi.org\/10.1016\/j.biopsych.2017.08.010","journal-title":"Biol Psychiatry"},{"issue":"7618","key":"3986_CR176","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/nature19323","volume":"537","author":"J Sevigny","year":"2016","unstructured":"Sevigny J, Chiao P, Bussi\u00e8re T, Weinreb PH, Williams L, Maier M et al (2016) The antibody aducanumab reduces A\u03b2 plaques in Alzheimer\u2019s disease. Nature 537(7618):50\u201356. https:\/\/doi.org\/10.1038\/nature19323","journal-title":"Nature"},{"issue":"7","key":"3986_CR177","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1038\/s41591-021-01369-8","volume":"27","author":"S Salloway","year":"2021","unstructured":"Salloway S, Farlow M, McDade E, Clifford DB, Wang G, Llibre-Guerra JJ et al (2021) A trial of gantenerumab or solanezumab in dominantly inherited Alzheimer\u2019s disease. Nat Med 27(7):1187\u20131196. https:\/\/doi.org\/10.1038\/s41591-021-01369-8","journal-title":"Nat Med"},{"issue":"18","key":"3986_CR178","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1056\/NEJMoa2100708","volume":"384","author":"MA Mintun","year":"2021","unstructured":"Mintun MA, Lo AC, Duggan Evans C, Wessels AM, Ardayfio PA, Andersen SW et al (2021) Donanemab in early Alzheimer\u2019s disease. N Engl J Med 384(18):1691\u20131704. https:\/\/doi.org\/10.1056\/NEJMoa2100708","journal-title":"N Engl J Med"}],"container-title":["Cellular and Molecular Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-021-03986-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00018-021-03986-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-021-03986-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,29]],"date-time":"2021-11-29T02:15:15Z","timestamp":1638152115000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00018-021-03986-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,27]]},"references-count":178,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["3986"],"URL":"https:\/\/doi.org\/10.1007\/s00018-021-03986-5","relation":{},"ISSN":["1420-682X","1420-9071"],"issn-type":[{"value":"1420-682X","type":"print"},{"value":"1420-9071","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,27]]},"assertion":[{"value":"16 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors declared no conflict of interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"No ethics approval was applicable to this work.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors provided consent to the publication of this study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}